Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')

被引：81
|
作者：
Ricaurte, GA
McCann, UD
Szabo, Z
Scheffel, U
机构：
[1] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21224 USA
[2] Johns Hopkins Med Inst, Dept Psychiat, Baltimore, MD 21224 USA
[3] Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD 21224 USA
来源：
TOXICOLOGY LETTERS | 2000年 / 112卷
关键词：
serotonin; neurotoxicity; amphetamines; PET; transporters; 3,4-methylenedioxy-methamphetamine;
D O I：
10.1016/S0378-4274(99)00216-7
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
The recreational drug, (+/-)3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), is a potent serotonin (5-HT) neurotoxin in animals. Whether humans who use MDMA incur 5-HT neural injury is unknown. The present studies utilized positron emission tomography (PET) in conjunction with the 5-HT transporter ligand, [C-11]McN-5652 to assess the status of brain 5-HT neurons in human MDMA users. Like nonhuman primates treated with neurotoxic doses of MDMA, humans with a history of MDMA use showed lasting decrements in global brain [C-11]McN-5652 binding, with decreases in [C-11]McN-5652 binding positively correlated to the extent of previous MDMA use. These results suggest that human MDMA use results in brain 5-HT neurotoxicity. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：143 / 146
页数：4
相关论文
共 50 条
  • [41] Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV)
    Papaseit, Esther
    Vazquez, Antonia
    Perez-Mana, Clara
    Pujadas, Mitona
    de la Torre, Rafael
    Farre, Magi
    Nolla, Joan
    [J]. INTENSIVE CARE MEDICINE, 2012, 38 (07) : 1239 - 1240
  • [42] Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
    Sunjeev K. Kamboj
    Ylva S. E. Walldén
    Caroline J. Falconer
    Majdah Raji Alotaibi
    Ian S. Blagbrough
    Stephen M. Husbands
    Tom P. Freeman
    [J]. Mindfulness, 2018, 9 : 1134 - 1145
  • [43] Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV)
    Esther Papaseit
    Antonia Vázquez
    Clara Pérez-Mañá
    Mitona Pujadas
    Rafael de la Torre
    Magí Farré
    Joan Nolla
    [J]. Intensive Care Medicine, 2012, 38 : 1239 - 1240
  • [44] 3,4-methylenedioxymethamphetamine (mdma): A review
    O’Leary G.
    Nargiso J.
    Weiss R.D.
    [J]. Current Psychiatry Reports, 2001, 3 (6) : 477 - 483
  • [45] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users
    McCann, Una D.
    Edwards, Robert R.
    Smith, Michael T.
    Kelley, Kristen
    Wilson, Michael
    Sgambati, Francis
    Ricaurte, George
    [J]. PSYCHOPHARMACOLOGY, 2011, 217 (04) : 475 - 484
  • [46] Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users:: a controlled study
    McCann, UD
    Mertl, M
    Eligulashvili, V
    Ricaurte, GA
    [J]. PSYCHOPHARMACOLOGY, 1999, 143 (04) : 417 - 425
  • [47] Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
    Wunderli, Michael D.
    Vonmoos, Matthias
    Treichler, Lorena
    Zeller, Carmen
    Dziobek, Isabel
    Kraemer, Thomas
    Baumgartner, Markus R.
    Seifritz, Erich
    Quednow, Boris B.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (04): : 333 - 344
  • [48] A new cause of valvular heart disease: 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy')
    Montastruc, F.
    Montastruc, G.
    Vigreux, P.
    Bruneval, P.
    Guilbeau-Frocher, C.
    Cron, C.
    Bagheri, H.
    Delisle, B.
    Lapeyre-Mestre, M.
    Pathak, A.
    Montastruc, J. L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 10 - 10
  • [49] Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')
    Montastruc, Francois
    Montastruc, Guillaume
    Vigreux, Philippe
    Bruneval, Patrick
    Guilbeau-Frugier, Celine
    Cron, Christophe
    Bagheri, Haleh
    Delisle, Bernadette
    Lapeyre-Mestre, Maryse
    Pathak, Atul
    Montastruc, Jean-Louis
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (03) : 547 - 548
  • [50] REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY)
    GREEN, AR
    CROSS, AJ
    GOODWIN, GM
    [J]. PSYCHOPHARMACOLOGY, 1995, 119 (03) : 247 - 260
12345